GSTM1 and metastatic malignant neoplasm in the lymph nodes: The risk factors for VTE at baseline obtained from our univariable analysis were female sex, age, cancer stage, lymph node metastasis, distant metastasis, ECOG PS, history of VTE, bed rest for 4 days or more, increased D-dimer level, low Hb, and high WBC count.